Your browser doesn't support javascript.
loading
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
O'Neil, Patrick M; Birkenfeld, Andreas L; McGowan, Barbara; Mosenzon, Ofri; Pedersen, Sue D; Wharton, Sean; Carson, Charlotte Giwercman; Jepsen, Cecilie Heerdegen; Kabisch, Maria; Wilding, John P H.
Afiliação
  • O'Neil PM; Medical University of South Carolina, Charleston, SC, USA.
  • Birkenfeld AL; Department and Outpatient Department of Medicine III, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.
  • McGowan B; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Mosenzon O; Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Pedersen SD; C-endo Diabetes and Endocrinology Clinic, Calgary, AB, Canada.
  • Wharton S; York University and Wharton Weight Management Clinic, Toronto, ON, Canada.
  • Carson CG; Novo Nordisk A/S, Søborg, Denmark.
  • Jepsen CH; Novo Nordisk A/S, Søborg, Denmark.
  • Kabisch M; Novo Nordisk A/S, Søborg, Denmark.
  • Wilding JPH; Obesity and Endocrinology Research, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK. Electronic address: j.p.h.wilding@liverpool.ac.uk.
Lancet ; 392(10148): 637-649, 2018 08 25.
Article em En | MEDLINE | ID: mdl-30122305

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Redução de Peso / Peptídeos Semelhantes ao Glucagon / Liraglutida / Obesidade Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Redução de Peso / Peptídeos Semelhantes ao Glucagon / Liraglutida / Obesidade Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article